PEOPLE - Changes at the NHS:
This article was originally published in Clinica
The UK National Health Service (NHS) has announced the members of its prostate brachytherapy advisory group. Ms Niki Bartrop (NHS commissioning advisor, Woking); Dr David Bottomley (consultant clinical oncologist, Cookeridge Hospital, Leeds); Professor Stephen Langley (chairman of the group - Professor of urology, St Luke's Cancer Centre, Guildford); Mr Richard Gledhill (prostate cancer charity specialist nurse, Queen Elizabeth Hospital, Birmingham); and Mr Richard Popert (consultant urological surgeon, Guy's and St Thomas' NHS Trust, London). The group has been formed to develop and improve the delivery of brachytherapy services in the UK.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.